Clinically-Relevant Rapamycin Treatment Regimens Enhance CD8+ Effector Memory T Cell Function In The Skin and Allow their Infiltration into Cutaneous Squamous Cell Carcinoma
Patients receiving immunosuppressive drugs to prevent organ transplant rejection exhibit a greatly increased risk of developing cutaneous squamous cell carcinoma (SCC). However, not all immunosuppressive drugs confer the same risk. Randomised, controlled trials demonstrate that switching renal trans...
Main Authors: | Ji-Won Jung, Margaret Veitch, Jennifer A. Bridge, Nana H. Overgaard, Jazmina L. Cruz, Richard Linedale, Michael E. Franklin, Nicholas A. Saunders, Fiona Simpson, Ian H. Frazer, Raymond J. Steptoe, James W. Wells |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-09-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2018.1479627 |
Similar Items
-
IFN-γ Critically Enables the Intratumoural Infiltration of CXCR3<sup>+</sup> CD8<sup>+</sup> T Cells to Drive Squamous Cell Carcinoma Regression
by: Zhen Zeng, et al.
Published: (2021-04-01) -
Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.
by: Laura Strauss, et al.
Published: (2009-06-01) -
Rapamycin Improves the Response of Effector and Memory CD8+ T Cells Induced by Immunization With ASP2 of Trypanosoma cruzi
by: Barbara Ferri Moraschi, et al.
Published: (2021-05-01) -
Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function
by: Brennan, D., et al.
Published: (2022) -
Single-cell transcriptomics reveals distinct effector profiles of infiltrating T cells in lupus skin and kidney
by: Billi, A.C, et al.
Published: (2022)